European biotechnology companies face structural constraints securing large-scale Series A and Series B venture capital funding relative to United States competitors

The political and economic union of European states — the broader institutional context for the European Research Council's funding of AI archaeology projects.

Early-stage companies building new products and seeking product-market fit.